Statements (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:disease
metabolic disorder |
gptkbp:affects |
humans
|
gptkbp:alsoKnownAs |
adult-onset diabetes
non-insulin-dependent diabetes mellitus |
gptkbp:causedBy |
combination of genetic and environmental factors
|
gptkbp:characterizedBy |
insulin resistance
relative insulin deficiency |
gptkbp:complication |
gptkb:cardiovascular_disease
stroke kidney failure poor wound healing peripheral neuropathy amputation retinopathy |
gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
gptkbp:guidanceSystem |
gptkb:American_Diabetes_Association_Standards_of_Care
gptkb:NICE_guidelines |
https://www.w3.org/2000/01/rdf-schema#label |
type 2 diabetes mellitus
|
gptkbp:ICD-10_code |
E11
|
gptkbp:MeSH_ID |
D003924
|
gptkbp:notablePerson |
gptkb:Halle_Berry
gptkb:Tom_Hanks |
gptkbp:OMIM |
125853
|
gptkbp:onset |
increasingly seen in children
usually in adults |
gptkbp:prevalence |
increasing worldwide
most common form of diabetes |
gptkbp:prevention |
weight loss
healthy diet regular physical activity |
gptkbp:riskFactor |
obesity
ethnicity physical inactivity older age family history of diabetes unhealthy diet |
gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst increased hunger |
gptkbp:treatment |
gptkb:metformin
gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents sulfonylureas insulin (in some cases) |
gptkbp:bfsParent |
gptkb:Type_2_diabetes
gptkb:Januvia gptkb:Steglatro gptkb:Galvus |
gptkbp:bfsLayer |
5
|